15-SORRENTO-Therapeutics-Logo-FINAL.png
SORRENTO DEVELOPS STI-4398 (COVIDTRAP™ PROTEIN) FOR POTENTIAL PREVENTION AND TREATMENT OF SARS-COV-2 CORONAVIRUS DISEASE (COVID-19)
20 mars 2020 07h00 HE | Sorrento Therapeutics, Inc.
COVIDTRAPTM is a proprietary ACE2-Fc protein that binds to the S1 domain of the spike protein of the SARS-CoV-2 virus;COVIDTRAP is designed to block the SARS-CoV-2 virus from binding and infecting...
“Are People with Celiac Disease At Greater Risk?’” and other Frequently Asked Questions Regarding COVID-19 and Celiac Disease
19 mars 2020 13h37 HE | Beyond Celiac
Philadelphia, PA, March 19, 2020 (GLOBE NEWSWIRE) -- Are people with celiac disease at greater risk for coronavirus? Is hand sanitizer safe for people with celiac disease? These are just two of the...
All-in-one.jpg
DATA443 DEPLOYS HIPPA AND PRIVACY ENABLED ARALOC™ FOR ALL COVID-19 RESPONDERS FREE OF CHARGE
17 mars 2020 10h04 HE | DATA443 Risk Mitigation Inc.
Open to any organizations of need – worldwideNo limits on usage or geographyProgram runs as long as crisis continues RALEIGH, N.C., March 17, 2020 (GLOBE NEWSWIRE) -- Data443 Risk Mitigation,...
Logo.jpg
Kiwa Bio-Tech Holds Annual Meeting and Its First Working Session of 2020 By Video Conference
18 févr. 2020 06h00 HE | Kiwa Bio-Tech Products Group Corp.
Yangling, Shaanxi, Feb. 18, 2020 (GLOBE NEWSWIRE) -- Kiwa Bio-Tech Products Group Corp. (OTCQB: KWBT) (“Kiwa Bio-Tech” or “the Company”), an emerging agricultural company that develops, manufactures...